MENU
APLM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Apollomics (APLM) Ownership - Who owns Apollomics?
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer... Show more
Profile
Industry
N/A
Address
989 East Hillsdale Boulevard
Phone
+1 650 209-4055
Employees
45
Web
https://www.apollomicsinc.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.62M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
4.72M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
APLM
Capitalization
6.62M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
4.72M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
20.8M
P/B Ratio
1.36
Cash Flow
N/A
Earnings
-15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
2.25
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-56.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-107.81
Shares Held By Institutions
757K
Shares Outstanding - Current
1.1M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
-31.179
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
989 East Hillsdale Boulevard
Phone
+1 650 209-4055
Employees
45
Web
https://www.apollomicsinc.com